Difference between revisions of "Polymorphous adenocarcinoma"

Jump to navigation Jump to search
Line 61: Line 61:
==IHC==
==IHC==
Features:<ref name=pmid23320410>{{Cite journal  | last1 = de Araujo | first1 = VC. | last2 = Passador-Santos | first2 = F. | last3 = Turssi | first3 = C. | last4 = Soares | first4 = AB. | last5 = de Araujo | first5 = NS. | title = Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists. | journal = Diagn Pathol | volume = 8 | issue =  | pages = 6 | month =  | year = 2013 | doi = 10.1186/1746-1596-8-6 | PMID = 23320410 }}</ref>
Features:<ref name=pmid23320410>{{Cite journal  | last1 = de Araujo | first1 = VC. | last2 = Passador-Santos | first2 = F. | last3 = Turssi | first3 = C. | last4 = Soares | first4 = AB. | last5 = de Araujo | first5 = NS. | title = Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists. | journal = Diagn Pathol | volume = 8 | issue =  | pages = 6 | month =  | year = 2013 | doi = 10.1186/1746-1596-8-6 | PMID = 23320410 }}</ref>
*S100 +ve.
*S-100 +ve.
*CK7 +ve.
*CK7 +ve.
*Vimentin +ve.
*Vimentin +ve.
48,466

edits

Navigation menu